<DOC>
	<DOCNO>NCT01501435</DOCNO>
	<brief_summary>To investigate safety pharmacokinetic property CJ-30039 Lipidil Supra</brief_summary>
	<brief_title>To Compare Safety Pharmacokinetic Properties CJ-30039 Lipidil Supra</brief_title>
	<detailed_description>Study objectives - To compare safety pharmacokinetic property CJ-30039 Lipidil Supra single oral administration healthy male volunteer . - To evaluate food-effect pharmacokinetics CJ-30039 single oral administration healthy male volunteer .</detailed_description>
	<mesh_term>Fenofibric acid</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Male volunteer age 20 55 year old BMI ( Body Mass Index ) range 18.5 25kg/m2 Subject history significant chronic disease History clinically significant allergy , include fenofibric acid Fenofibrate History clinically significant hepatic , renal , neurology , psychiatric , pulmonary , endocrine , hematologic , cardiovascular disease History surgery except gastrointestinal disease might significantly change absorption medicine Clinical laboratory test value outside accept normal range AST ( ASpartate Transaminase ) , ALT ( ALanine Transaminase ) ( &gt; 1.25 time normal range Total bilirubin &gt; 1.5 time normal range BUN ( Blood Urea Nitrogen ) &gt; 25 mg/dL Creatinine &gt; 1.4 mg/dL CK ( Creatine Kinase ) &gt; 1.25 time normal range Estimated GFR ( Glomerular Filtration Rate ) &lt; 80 mL/min/1.73m2 Clinically significant vital sign SBP ( Systolic Blood Pressure ) ≤ 90 mmHg SBP ≥ 150 mmHg DBP ( Diastolic Blood Pressure ) ≤ 50 mmHg DBP ≥ 100 mmHg History drug abuse positive urine screen drug History caffeine , alcohol , smoke abuse caffeine &gt; 5 cups/day alcohol &gt; 201g/week smoking &gt; 10 cigarettes/day Use prescription medicine oriental medicine within 14 day dose use nonprescription medicine within 7 day dose Participated previous clinical trial within 60 day prior dose Donated blood within 60 day prior dose</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Safety</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>